Difference between revisions of "Talk:SUIT-006 MgG mt D055"
From Bioblast
| Line 36: | Line 36: | ||
| [[Carboxyatractyloside#Application_in_HRR|Carboxyatractyloside]] | | [[Carboxyatractyloside#Application_in_HRR|Carboxyatractyloside]] | ||
| Cat | | Cat | ||
| Can be substituted for [[ | | Can be substituted for [[Oligomycin#Application_in_HRR|oligomycin]] | ||
|- | |- | ||
| Uncoupler: in this DLP, [[SF6847#Application_in_HRR|SF6847]] was used | | Uncoupler: in this DLP, [[SF6847#Application_in_HRR|SF6847]] was used | ||
Revision as of 14:56, 2 September 2020
Chemicals and syringes needed
| Chemical and link | Abbreviation | Comments |
|---|---|---|
| Magnesium Green | MgG | |
| MgCl2 | Mg |
| Chemical and link | Abbreviation | Comments |
|---|---|---|
| Pyruvate | P | Can be substituted by other combination of substrates |
| Malate | M | Can be substituted by other combination of substrates |
| ADP | D | For this protocol, the ADP must be prepared without Mg2+ salts. |
| Carboxyatractyloside | Cat | Can be substituted for oligomycin |
| Uncoupler: in this DLP, SF6847 was used | U | Can be substituted for other uncoupler |
| Antimycin A | Ama | Can be substituted for other CIII or CIV inhibitor |
